Quick Dispatch:
Your crohn's disease and glp-1 GLP-1 Agonists and Crohn's Disease: Risks and Management orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your crohn's disease and glp-1 GLP-1 Agonists and Crohn's Disease: Risks and Management ships.
Need Help?
Questions about crohn's disease and glp-1 GLP-1 Agonists and Crohn's Disease: Risks and Management, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for crohn's disease and glp-1 GLP-1 Agonists and Crohn's Disease: Risks and Management in your area.
New research published in the Foundation's journal Crohn's & Colitis 360 found that people with IBD who use GLP-1 medications—commonly prescribed for diabetes and obesity—had a lower risk of major heart-related complications
27.96
Pharmacological Interventions for Obesity in Patients with Inflammatory Bowel Disease: A Systematic Review of GLP-1 Receptor Agonist Efficacy and Safety
20.01
GLP-1 for Crohn's Disease: Current Evidence and Treatment Options
25.94
Relevance of Glucagon-Like Peptide 1 (GLP-1) in Inflammatory Bowel Diseases: A Narrative Review
26.30
Ozempic and Crohn's Disease: Could GLP-1s Help?
27.97
Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology
29.90
A surprising role for enteroendocrine cells and GLP-1 in regulating intestinal inflammation
26.62
